18. 脊髄小脳変性症(多系統萎縮症を除く。) Spinocerebellar degeneration Clinical trials / Disease details


臨床試験数 : 71 薬物数 : 101 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05285540
(ClinicalTrials.gov)
March 7, 20229/3/2022Study to Evaluate DT-216 in Adult Patients With Friedreich AtaxiaA Phase 1a, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of DT-216 in Adult Patients With Friedreich AtaxiaFriedreich AtaxiaDrug: DT-216;Drug: DT-216 matching PlaceboDesign TherapeuticsNULLRecruiting18 Years55 YearsAll25Phase 1United States